Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 — St Louis, Missouri

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors.

Sponsors: EDDC (Experimental Drug Development Centre), A*STAR Research Entities.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205?

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 conducted?

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors.

Is Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 accredited by Crixeo Health?

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place, Site 205?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.